← Latest papers
🦠 microbiology

Six years of clinical herpes simplex virus genotypic acyclovir resistance testing confirms common resistance mechanisms and identifies novel mutations

This six-year retrospective study of the first US clinical genotypic HSV resistance testing program confirms that frameshift mutations are a primary driver of acyclovir resistance while identifying 23 novel UL23 variants to guide future characterization and therapeutic decision-making.

Original authors: Crawford, K. H. D., Castor, J., LaTurner, K., Mack, A. R., Pepper, G., Greninger, A. L.

Published 2026-06-27
📖 3 min read☕ Coffee break read

Original authors: Crawford, K. H. D., Castor, J., LaTurner, K., Mack, A. R., Pepper, G., Greninger, A. L.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine the Herpes Simplex Virus (HSV) as a tiny burglar trying to break into a house. The "house" is the human body, and the "lock" it tries to pick is a specific protein called UL23. Doctors usually use a medicine called acyclovir to jam this lock, stopping the burglar from entering. However, sometimes the burglar learns to change the shape of its tools so the medicine no longer works. This is called resistance.

For a long time, figuring out if a burglar had changed its tools was like trying to guess by looking at the footprints left behind (phenotypic testing). It was slow and took a lot of time.

The New Tool: A Genetic Blueprint
In 2020, a lab at the University of Washington introduced a new way to catch these resistant burglars. Instead of waiting for footprints, they started reading the burglar's genetic blueprint (genotypic testing). This is like checking the burglar's ID card to see exactly what tools they are carrying. This new method is much faster, giving doctors answers in about 10 days instead of weeks.

What They Found Over Six Years
The researchers looked back at nearly six years of data (from 2020 to late 2025) and examined 136 of these genetic blueprints. Here is what they discovered:

  • The "Broken Tool" Problem: Almost half of the samples (48%) showed that the virus had mutations that made the medicine useless. A huge chunk of these were frameshift mutations. Think of this like a burglar who accidentally dropped a letter out of their instruction manual. Because one letter is missing, every single instruction after that point becomes gibberish, and the tool they build is completely broken and useless. This "broken manual" is a very common way the virus becomes resistant.
  • The Mystery Variants: The researchers found that in about 73% of the cases, the mutations they saw were things they hadn't seen before in their rulebooks. It was like finding 56 different types of new, strange tools that no one had cataloged yet.
  • The New Discoveries: Out of all those strange new tools, they identified 23 specific mutations that had never been described or understood before. These are like finding 23 completely new types of lock-picking tools that scientists have never seen in a museum.

The Bottom Line
This study confirms that reading the virus's genetic blueprint is a fast and effective way to tell doctors if their medicine will work. It also confirms that "broken manuals" (frameshift mutations) are a major reason why the virus stops responding to treatment. Most importantly, by spotting these 23 brand-new, unknown mutations, the researchers have handed scientists a "Wanted List" of new targets. Now, other scientists know exactly which strange tools they need to study next to understand how the virus fights back.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →